Heterogeneous nuclear ribonucleoprotein A2/B1 is a negative regulator of human breast cancer metastasis by maintaining the balance of multiple genes and pathways

Yu Liu, Huan Li, Fan Liu, Li-Bin Gao, Rong Han, Chen Chen, Xue Ding, Shuang Li, Kun Lu, Ling Yang, Hui-Min Tian, Bin-Bin Chen, Xiao Li, Dong-Hui Xu, Xiao-Ling Deng, Song-Lin Shi

Open source

DOI
10.1016/j.ebiom.2019.11.044
Published
2020-01
Container
EBioMedicine
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ebiom.2019.11.044,
  title = {Heterogeneous nuclear ribonucleoprotein A2/B1 is a negative regulator of human breast cancer metastasis by maintaining the balance of multiple genes and pathways},
  author = {Yu Liu and Huan Li and Fan Liu and Li-Bin Gao and Rong Han and Chen Chen and Xue Ding and Shuang Li and Kun Lu and Ling Yang and Hui-Min Tian and Bin-Bin Chen and Xiao Li and Dong-Hui Xu and Xiao-Ling Deng and Song-Lin Shi},
  year = {2020},
  journal = {EBioMedicine},
  doi = {10.1016/j.ebiom.2019.11.044},
  url = {https://doi.org/10.1016/j.ebiom.2019.11.044}
}

RIS

TY  - JOUR
TI  - Heterogeneous nuclear ribonucleoprotein A2/B1 is a negative regulator of human breast cancer metastasis by maintaining the balance of multiple genes and pathways
AU  - Yu Liu
AU  - Huan Li
AU  - Fan Liu
AU  - Li-Bin Gao
AU  - Rong Han
AU  - Chen Chen
AU  - Xue Ding
AU  - Shuang Li
AU  - Kun Lu
AU  - Ling Yang
AU  - Hui-Min Tian
AU  - Bin-Bin Chen
AU  - Xiao Li
AU  - Dong-Hui Xu
AU  - Xiao-Ling Deng
AU  - Song-Lin Shi
PY  - 2020
JO  - EBioMedicine
DO  - 10.1016/j.ebiom.2019.11.044
UR  - https://doi.org/10.1016/j.ebiom.2019.11.044
ER  - 

APA

Liu, Y., Li, H., Liu, F., Gao, L., Han, R., Chen, C., Ding, X., Li, S., Lu, K., Yang, L., Tian, H., Chen, B., Li, X., Xu, D., Deng, X., & Shi, S. (2020). Heterogeneous nuclear ribonucleoprotein A2/B1 is a negative regulator of human breast cancer metastasis by maintaining the balance of multiple genes and pathways. EBioMedicine. https://doi.org/10.1016/j.ebiom.2019.11.044

Source records